Intra-articular injection of clindamycin in reducing postoperative infection rate of total knee arthroplasty
Phase 3
- Conditions
- Other and unspecified infectious diseasesTotal knee arthroplasty.
- Registration Number
- IRCT20240213061004N1
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 958
Inclusion Criteria
Patients with Degenerative Joint Disease
Indications for total knee arthroplasty
Informed consent
Exclusion Criteria
Lack of consent to participate in the study
Suffering a disease other than degenerative joint disease
Hypersensitivity to any of the drugs used in the study
Dissatisfaction with performing total knee arthroplasty
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Infection. Timepoint: 2 weeks, 1 month and 3 months. Method of measurement: Pain, heat, redness, swelling. If these symptoms are present, CRP and ESR are tested. If the results of the tests are abnormal, a smear and culture will be done for the patient from joint fluid aspiration, and if the results are positive, the case of joint infection will be known.
- Secondary Outcome Measures
Name Time Method